我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
60
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1971
进行中（未招募）
1
1.7%
已完成
46
76.7%
尚未招募
招募中
2
3.3%
终止
7
11.7%
撤回
3
5.0%
暂无批准数据
- Daré Bioscience and Theramex have entered into a co-development agreement for Casea S, a first-in-category biodegradable contraceptive implant designed to last 18-24 months. - The innovative implant eliminates the need for surgical removal, addressing a key barrier in current contraceptive implants while offering women a convenient, long-acting contraceptive option. - A foundation-funded Phase 1 trial is currently underway to evaluate the pharmacokinetics, removability, safety, and tolerability of Casea S.
